XENE · Forms 3, 4, 5
Insider trades at Xenon Pharmaceuticals Inc.
2 insiders bought $1.7M of Xenon Pharmaceuticals Inc. stock on the open market in the last 30 days.
Every Form 3, 4 and 5 filed for Xenon Pharmaceuticals Inc. (XENE) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Thomas Patrick Kelly | Chief Financial Officer | Option exercise | 7,500 | Form 4 | |||
| Thomas Patrick Kelly | Chief Financial Officer | Buy | 15,000 | $37.32 | $560K | Form 4 | |
| Ian Mortimer | PRESIDENT & CEO | Buy | 30,000 | $37.38 | $1.1M | Form 4 | |
| Dawn Svoronos | Director | Option exercise | 5,144 | $8.15 | $42K | Form 4 | |
| Christopher John Kenney | Chief Medical Officer | Sell (10b5-1 plan) | 6,368 | $60.17 | $383K | Form 4 | |
| Christopher John Kenney | Chief Medical Officer | Sell (10b5-1 plan) | 700 | $60.98 | $43K | Form 4 | |
| Steven Gannon | Director | Sell | 10,000 | $64.06 | $641K | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.